Joint United Nations Programme on HIV/AIDS: The gap report. Geneva: UNAIDS 2014.
Uganda AIDS Commission: HIV and AIDS Uganda Country progress report; 2014. Kampala: Uganda AIDS Commission 2015.
Joint United Nations Programme on HIV/AIDS: 90–90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS 2014.
Uganda AIDS. Commission: national HIV AND AIDS Strategic Plan 2015/2016-2019/2020. In Uganda. 2015;
Ying R, Sharma M, Celum C, Baeten JM, van Rooyen H, Hughes JP, Garnett G, Barnabas RV. Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis. The Lancet HIV. 2016;3(6):e275–82.
Bershteyn A, Klein DJ, Eckhoff PA: Age-targeted HIV treatment and primary prevention as a ‘ring fence’to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South Africa. International health 2016:ihw010.
Mitchell KM, Lépine A, Terris-Prestholt F, Torpey K, Khamofu H, Folayan MO, Musa J, Anenih J, Sagay AS, Alhassan E: Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria. AIDS (London, England) 2015, 29(15):2035.
Smith JA, Sharma M, Levin C, Baeten JM, van Rooyen H, Celum C, Hallett TB, Barnabas RV. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. The Lancet HIV. 2015;2(4):e159–68.
Alistar SS, Grant PM, Bendavid E. Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa. BMC Med. 2014;12(1):1.
Ishikawa N, Shimbo T, Miyano S, Sikazwe I, Mwango A, Ghidinelli MN, Syakantu G. Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia. PLoS One. 2014;9(3):e90991.
Braithwaite RS, Nucifora KA, Toohey C, Kessler J, Uhler LM, Mentor SM, Keebler D, Hallett T: How do different eligibility guidelines for antiretroviral therapy affect the cost–effectiveness of routine viral load testing in sub-Saharan Africa? AIDS (London, England) 2014, 28(0 1):S73.
Gopalappa C, Stover J, Shaffer N, Mahy M. The costs and benefits of option B+ for the prevention of mother-to-child transmission of HIV. AIDS. 2014;28:S5–S14.
Klein DJ, Bershteyn A, Eckhoff PA. Dropout and re-enrollment: implications for epidemiological projections of treatment programs. AIDS. 2014;28:S47–59.
Long EF, Stavert RR. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med. 2013;28(10):1294–301.
Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, Hallett TB. The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS. 2013;27(3):447–58.
Bärnighausen T, Bloom DE, Humair S. Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc Natl Acad Sci. 2012;109(52):21271–6.
Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, Sabin ML, Makhlouf-Obermeyer C, Mack CDF, Williams P. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One. 2012;7(2):e30216.
Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, Cremin Í, Delany S, Garnett GP, Gray G, Johnson L. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med. 2011;8(11):e1001123.
Hontelez JA, De Vlas SJ, Tanser F, Bakker R, Bärnighausen T, Newell M-L, Baltussen R, Lurie MN. The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS One. 2011;6(7):e21919.
Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57.
World Health Organization: Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. In.; 2015.
Wilensky U. NetLogo. Center for Connected Learning and Computer-Based Modeling: Northwestern University, Evanston, IL; 1999.
Kaleebu P, Kamali A, Seeley J, Elliott A, Katongole-Mbidde E. The Medical Research Council (UK)/Uganda virus research Institute Uganda research unit on AIDS–‘25 years of research through partnerships’. Tropical Med Int Health. 2014;
McCreesh N, O'Brien K, Nsubuga RN, Shafer LA, Bakker R, Seeley J, Hayes RJ, White RG: Exploring the potential impact of a reduction in partnership concurrency on HIV incidence in rural Uganda: A modeling study. Sexually Transmitted Diseases 2012, 39(6):407–413 410.1097/OLQ.1090b1013e318254c318284a.
STD/AIDS Control Programme MoH: Status of Antiretroviral Therapy Services in Uganda: Semi-Annual ART Report for January – June 2014. In. Kampala, Uganda; 2014.
STD/AIDS Control Programme MoH: Status of Antiretroviral Therapy Service Delivery in Uganda Quarterly Report for March – June 2010. In. Kampala, Uganda; 2010.
Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, Rutebemberwa A, Lyagoba F, Hamilton L, Biryahwaho B, Whitworth J. Relationship between HIV-1 Env subtypes a and D and disease progression in a rural Ugandan cohort. AIDS. 2001;15(3):293–9.
STD/AIDS Control Programme MoH: Status of Antiretroviral Therapy Service Delivery in Uganda Quarterly Report for July – September 2010. In. Kampala, Uganda; 2010.
Andrianakis I, Vernon I, McCreesh N, McKinley TJ, Oakley JE, Nsubuga R, Goldstein M, White RG. Efficient history matching of a high dimensional individual based HIV transmission model. J Uncertain Quantif. in press.
Andrianakis I, Vernon IR, McCreesh N, McKinley TJ, Oakley JE, Nsubuga RN, Goldstein M, White RG. Bayesian history matching of complex infectious disease models using emulation: a tutorial and a case study on HIV in Uganda. PLoS Comput Biol. 2015;11(1):e1003968.
Uganda Ministry of Health: Addendum To The Antiretroviral Treatment Guidelines For Uganda. In. Kampala, Uganda; 2013.
Global Price Reporting Mechnism.
Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS (London, England) 2011, 25(14):1753.
Nichols BE, Sigaloff KC, Kityo C, Hamers RL, Baltussen R, Bertagnolio S, Jordan MR, Hallett TB, Boucher CA, de Wit TF van de Vijver DA. Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study. J Int AIDS Soc 2014, 17(1).
Mulogo E, Batwala V, Nuwaha F, Aden A, Baine O. Cost effectiveness of facility and home based HIV voluntary counseling and testing strategies in rural Uganda. Afr Health Sci. 2013;13(2):423–9.
Kahn JG, Marseille E, Moore D, Bunnell R, Were W, Degerman R, Tappero JW, Ekwaru P, Kaharuza F, Mermin J. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011;343:d6884.
Lara AM, Kigozi J, Amurwon J, Muchabaiwa L, Wakaholi BN, Mota REM, Walker AS, Kasirye R, Ssali F, Reid A. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. PLoS One. 2012;7(4)
Pitter C, Kahn JG, Marseille E, Lule JR, McFarland DA, Ekwaru JP, Bunnell R, Coutinho A, Mermin J. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr. 2007;44(3):336–43.
Mermin J, Were W, Ekwaru JP, Moore D, Downing R, Behumbiize P, Lule JR, Coutinho A, Tappero J, Bunnell R. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet. 2008;371(9614):752–9.
Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet. 2004;364(9443):1428–34.
Menzies N, Abang B, Wanyenze R, Nuwaha F, Mugisha B, Coutinho A, Bunnell R, Mermin J, Blandford JM. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS. 2009;23(3):395–401.
Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDs. 2010;24(11):735–41.
Chang LW, Kagaayi J, Nakigozi G, Ssempijja V, Packer AH, Serwadda D, Quinn TC, Gray RH, Bollinger RC, Reynolds SJ. Effect of peer health workers on AIDS Care in Rakai, Uganda: A Cluster-Randomized Trial. PLoS ONE. 2010;5(6):e10923.
Chang LW, Kagaayi J, Nakigozi G, Serwadda D, Quinn TC, Gray RH, Bollinger RC, Reynolds SJ, Holtgrave D. Cost analyses of peer health worker and mHealth support interventions for improving AIDS care in Rakai, Uganda. AIDS Care. 2013;25(5):652–6.